Genentech outlines R&D efforts

06/11/2008 | Wall Street Journal, The

Genentech intends to pursue research in neuroscience and infectious diseases as well as seek new uses for top-selling drugs, a company official said at a health care conference. The firm's Avastin -- on the market to treat breast, colon and lung cancers -- is being studied on people with renal cancer and certain kinds of brain tumors. Genentech also is working on 14 novel molecules to treat different cancers, said Susan Desmond-Hellmann, president of product development.

View Full Article in:

Wall Street Journal, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Paralegal
Mylan Inc.
Washington, DC
Health Care Exchange Account Manager
Kaiser Permanente
San Diego, CA
Director of Actuarial Services, Government Programs
PacificSource
Springfield, OR
Director, Health Plan Claims Operations
Group Health Cooperative
Seattle, WA
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC